Startups
myTomorrows
myTomorrows is an Amsterdam-based health technology company founded by physician Ronald Brus in 2012, with an additional office in New York. Its platform uses AI-supported clinical-trial discovery, treatment matching and patient pre-screening alongside human navigation to connect patients, clinicians, research sites and biopharma companies. It also supports expanded-access programs and real-world data collection. Applications cover serious diseases, including neurological and rare conditions. Michel van Harten leads the company, with Dennis Akkaya overseeing commercial strategy, Vanessa Lemarié operations and Marshall van Beurden technology. Verified funding includes a EUR4.5 million institutional investment in 2014, EUR10 million growth financing in January 2017 and EUR25 million growth equity in November 2025 from Avego Healthcare Capital Fund II. The latter was also announced as USD29 million; both figures describe the same round. The website identifies its publishing legal entity as Impatients N.V.
Founded 2012
Team
 Danny den HamerProduct Manager |
 Dennis AkkayaChief Commercial Officer |
 Karlijn DoornHead of Pharma Partnerships and Customer Success |
 Laura CoxDirector, Partnerships Development |
Madeleine PagelPatient Navigator |
 Marshall van BeurdenChief Technology Officer |
 Michel van HartenChief Executive Officer |
Romina DibraSenior Site Manager |
 Ronald BrusFounder · Board Director |
 Vanessa LemariéChief Operating Officer |